Access to anti-retroviral drugs, female in Kazakhstan
Kazakhstan: Access to anti-retroviral drugs, female was 60.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Kazakhstan, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Kazakhstan is 60.0%, measured in 2024. That is the highest value across all 25 years on record.
That represents a change of up 5.3% on the previous year and up 275.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Kazakhstan peaked at 60.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Kazakhstan 103rd out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Kazakhstan, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 2.0% | — |
| 2006 | 2.0% | +0.0% |
| 2007 | 2.0% | +0.0% |
| 2008 | 3.0% | +50.0% |
| 2009 | 4.0% | +33.3% |
| 2010 | 5.0% | +25.0% |
| 2011 | 7.0% | +40.0% |
| 2012 | 10.0% | +42.9% |
| 2013 | 13.0% | +30.0% |
| 2014 | 16.0% | +23.1% |
| 2015 | 20.0% | +25.0% |
| 2016 | 24.0% | +20.0% |
| 2017 | 33.0% | +37.5% |
| 2018 | 41.0% | +24.2% |
| 2019 | 44.0% | +7.3% |
| 2020 | 48.0% | +9.1% |
| 2021 | 51.0% | +6.2% |
| 2022 | 54.0% | +5.9% |
| 2023 | 57.0% | +5.6% |
| 2024 | 60.0% | +5.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.3% | 0.0% | 4.0% | 10 |
| 2010s | 21.3% | 5.0% | 44.0% | 10 |
| 2020s | 54.0% | 48.0% | 60.0% | 5 |
Countries ranked near Kazakhstan
More gender data for Kazakhstan
- Child population (UN estimates and projections) 6,050 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.2514 % change on previous year (2030)
- Population 15,953 (2030)
- Working-age population (UN estimates and projections) 15,953 (2030)
- Population (UN estimates and projections), annual growth rate 1.54 % change on previous year (2030)
- Age population, age 00, female, interpolated 192,023 (2025)
- Age population, age 00, male, interpolated 204,014 (2025)
- Age population, age 01, female, interpolated 195,086 (2025)
- Age population, age 01, male, interpolated 207,220 (2025)
- Age population, age 02, female, interpolated 198,672 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Kazakhstan?
- Access to anti-retroviral drugs, female in Kazakhstan was 60.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Kazakhstan?
- The highest recorded value was 60.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Kazakhstan?
- The lowest recorded value was 0.0% in 2000.
- How does Kazakhstan rank for access to anti-retroviral drugs, female?
- Kazakhstan ranks 103rd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Kazakhstan?
- Over the last ten years it is up 275.0%. The long-run trend across the full record is volatile.
- Where does this Kazakhstan data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.